{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:27:35Z","timestamp":1761128855329},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,8,28]],"date-time":"2010-08-28T00:00:00Z","timestamp":1282953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s11908-010-0130-3","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T04:29:55Z","timestamp":1282883395000},"page":"444-449","source":"Crossref","is-referenced-by-count":4,"title":["Challenges and Prospects of Adoptive Immunotherapy in Prevention and Treatment of Opportunistic Mycoses in Hematologic Transplant Recipients"],"prefix":"10.1007","volume":"12","author":[{"given":"Lars","family":"Tramsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislaw","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Roeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Koehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,28]]},"reference":[{"key":"130_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","volume":"48","author":"D Neofytos","year":"2009","unstructured":"\u2022 Neofytos D, Horn D, Anaissie E, et al.: Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009, 48:265\u2013273. This article reports one of the few larger studies on epidemiology and outcome of invasive fungal infections in transplant recipients.","journal-title":"Clin Infect Dis"},{"key":"130_CR2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"\u2022\u2022 De Pauw B, Walsh TJ, Donnelly JP, et al.: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813\u20131821. This article presents the revised definitions of invasive fungal infections used in all major clinical trials.","journal-title":"Clin Infect Dis"},{"key":"130_CR3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","volume":"45","author":"L Pagano","year":"2007","unstructured":"Pagano L, Caira M, Nosari A, et al.: Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study\u2014Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007, 45:1161\u20131170.","journal-title":"Clin Infect Dis"},{"key":"130_CR4","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","volume":"110","author":"D Caillot","year":"2007","unstructured":"Caillot D, Thiebaut A, Herbrecht R, et al.: Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial). Cancer 2007, 110:2740\u20132746.","journal-title":"Cancer"},{"key":"130_CR5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","volume":"44","author":"OA Cornely","year":"2007","unstructured":"\u2022 Cornely OA, Maertens J, Bresnik M, et al.: Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007, 44:1289\u20131297. This randomized study evaluates the benefit of high-dose liposomal amphotericin B.","journal-title":"Clin Infect Dis"},{"key":"130_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0891-5520(02)00070-3","volume":"17","author":"E Roilides","year":"2003","unstructured":"Roilides E, Lyman CA, Panagopoulou P, Chanock S: Immunomodulation of invasive fungal infections. Infect Dis Clin North Am 2003, 17:193\u2013219.","journal-title":"Infect Dis Clin North Am"},{"key":"130_CR7","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.21929","volume":"106","author":"A Safdar","year":"2006","unstructured":"Safdar A, Rodriguez GH, Lichtiger B, et al.: Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer 2006, 106:2664\u20132671.","journal-title":"Cancer"},{"key":"130_CR8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/513943","volume":"26","author":"DW Denning","year":"1998","unstructured":"Denning DW: Invasive aspergillosis. Clin Infect Dis 1998, 26:781\u2013803; quiz 804\u2013785.","journal-title":"Clin Infect Dis"},{"key":"130_CR9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","volume":"175","author":"A Wald","year":"1997","unstructured":"Wald A, Leisenring W, van Burik JA, Bowden RA: Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997, 175:1459\u20131466.","journal-title":"J Infect Dis"},{"key":"130_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2008.02.014","volume":"335","author":"O Beck","year":"2008","unstructured":"Beck O, Koehl U, Tramsen L, et al.: Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood. J Immunol Methods 2008, 335:41\u201345.","journal-title":"J Immunol Methods"},{"key":"130_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","volume":"165","author":"E Cenci","year":"2000","unstructured":"Cenci E, Mencacci A, Bacci A, et al.: T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000, 165:381\u2013388.","journal-title":"J Immunol"},{"key":"130_CR12","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","volume":"100","author":"H Hebart","year":"2002","unstructured":"Hebart H, Bollinger C, Fisch P, et al.: Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood 2002, 100:4521\u20134528.","journal-title":"Blood"},{"key":"130_CR13","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","volume":"99","author":"H Einsele","year":"2002","unstructured":"Einsele H, Roosnek E, Rufer N, et al.: Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002, 99:3916\u20133922.","journal-title":"Blood"},{"key":"130_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","volume":"134","author":"T Feuchtinger","year":"2006","unstructured":"Feuchtinger T, Matthes-Martin S, Richard C, et al.: Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006, 134:64\u201376.","journal-title":"Br J Haematol"},{"key":"130_CR15","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2003-12-4287","volume":"103","author":"HJ Wagner","year":"2004","unstructured":"Wagner HJ, Cheng YC, Huls MH, et al.: Prompt versus preemptive intervention for EBV lymphoproliferative disease. Blood 2004, 103:3979\u20133981.","journal-title":"Blood"},{"key":"130_CR16","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2005-04-1660","volume":"107","author":"O Beck","year":"2006","unstructured":"Beck O, Topp MS, Koehl U, et al.: Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006, 107:2562\u20132569.","journal-title":"Blood"},{"key":"130_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/519389","volume":"196","author":"L Tramsen","year":"2007","unstructured":"Tramsen L, Beck O, Schuster FR, et al.: Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant. J Infect Dis 2007, 196:485\u2013492.","journal-title":"J Infect Dis"},{"key":"130_CR18","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","volume":"168","author":"V Appay","year":"2002","unstructured":"Appay V, Zaunders JJ, Papagno L, et al.: Characterization of CD4(+) CTLs ex vivo. J Immunol 2002, 168:5954\u20135958.","journal-title":"J Immunol"},{"key":"130_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/14653240410006040","volume":"6","author":"G Ramadan","year":"2004","unstructured":"Ramadan G, Konings S, Kurup VP, Keever-Taylor CA: Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC. Cytotherapy 2004, 6:223\u2013234.","journal-title":"Cytotherapy"},{"key":"130_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/bmt.2008.271","volume":"43","author":"L Tramsen","year":"2009","unstructured":"\u2022\u2022 Tramsen L, Koehl U, Tonn T, et al.: Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy. Bone Marrow Transplant 2009, 43:13\u201319. This paper describes for the first time a method for the clinical-scale generation of antifungal T cells.","journal-title":"Bone Marrow Transplant"},{"key":"130_CR21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","volume":"12","author":"JP Latge","year":"1999","unstructured":"Latge JP: Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999, 12:310\u2013350.","journal-title":"Clin Microbiol Rev"},{"key":"130_CR22","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","volume":"183","author":"S Bozza","year":"2009","unstructured":"\u2022\u2022 Bozza S, Clavaud C, Giovannini G, et al.: Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol 2009, 183:2407\u20132014. This study analyzes the cellular host response to various recombinant Aspergillus antigens.","journal-title":"J Immunol"},{"key":"130_CR23","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","volume":"114","author":"PJ Hanley","year":"2009","unstructured":"Hanley PJ, Cruz CR, Savoldo B, et al.: Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood 2009, 114:1958\u20131967.","journal-title":"Blood"},{"key":"130_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trsl.2007.06.003","volume":"150","author":"Y Sun","year":"2007","unstructured":"Sun Y, Tawara I, Toubai T, Reddy P: Pathophysiology of acute graft-versus-host disease: recent advances. Transl Res 2007, 150:197\u2013214.","journal-title":"Transl Res"},{"key":"130_CR25","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1182\/blood-2003-09-3056","volume":"103","author":"G Rauser","year":"2004","unstructured":"Rauser G, Einsele H, Sinzger C, et al.: Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 2004, 103:3565\u20133572.","journal-title":"Blood"},{"key":"130_CR26","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","volume":"106","author":"K Perruccio","year":"2005","unstructured":"Perruccio K, Tosti A, Burchielli E, et al.: Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 2005, 106:4397\u20134406.","journal-title":"Blood"},{"key":"130_CR27","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","volume":"114","author":"AM Leen","year":"2009","unstructured":"Leen AM, Christin A, Myers GD, et al.: Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 2009, 114:4283\u20134292.","journal-title":"Blood"},{"key":"130_CR28","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20040890","volume":"200","author":"CM Bollard","year":"2004","unstructured":"Bollard CM, Aguilar L, Straathof KC, et al.: Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin\u2019s disease. J Exp Med 2004, 200:1623\u20131633.","journal-title":"J Exp Med"},{"key":"130_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V97.1.63","volume":"97","author":"P Tiberghien","year":"2001","unstructured":"Tiberghien P, Ferrand C, Lioure B, et al.: Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 2001, 97:63\u201372.","journal-title":"Blood"},{"key":"130_CR30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.beha.2006.06.004","volume":"19","author":"JR Passweg","year":"2006","unstructured":"Passweg JR, Koehl U, Uharek L, et al.: Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 2006, 19:811\u2013824.","journal-title":"Best Pract Res Clin Haematol"},{"key":"130_CR31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2009.01.019","volume":"15","author":"S Gill","year":"2009","unstructured":"Gill S, Olson JA, Negrin RS: Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses. Biol Blood Marrow Transplant 2009, 15:765\u2013776.","journal-title":"Biol Blood Marrow Transplant"},{"key":"130_CR32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","volume":"110","author":"L Ruggeri","year":"2007","unstructured":"Ruggeri L, Mancusi A, Capanni M, et al.: Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 2007, 110:433\u2013440.","journal-title":"Blood"},{"key":"130_CR33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2057","volume":"7","author":"KC Newman","year":"2007","unstructured":"Newman KC, Riley EM: Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007, 7:279\u2013291.","journal-title":"Nat Rev Immunol"},{"key":"130_CR34","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI18125","volume":"112","author":"BE Morrison","year":"2003","unstructured":"Morrison BE, Park SJ, Mooney JM, Mehrad B: Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003, 112:1862\u20131870.","journal-title":"J Clin Invest"},{"key":"130_CR35","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.0803462","volume":"182","author":"SJ Park","year":"2009","unstructured":"Park SJ, Hughes MA, Burdick M, et al.: Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol 2009, 182:4306\u20134312.","journal-title":"J Immunol"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0130-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-010-0130-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0130-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:22:14Z","timestamp":1559434934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-010-0130-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,28]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s11908-010-0130-3","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,28]]}}}